The major brands in China’s urinalysis market are URIT, DIRUI, AVE, etc. URIT produced China’s first urine analyzer in 1984. And after nearly 40 years’ strenuous cultivation, it pioneered the modular urine analysis workflow using deep learning artificial intelligence (AI) image recognition technology.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Roche announced on Monday that its Elecsys HCV Duo test for hepatitis C virus (HCV) received CE marking, and it is launching in countries accepting the regulatory approval.

Recently, during the first ZAODX World Cancer Early Screening Conference, Zhu Yeqing, CEO of New Horizon Health Ltd, said that according to CAIVD statistics, there are 58 listed enterprises with IVD business in China by the end of 2021, with a total revenue of 145.032 billion CNY

The director of Columbia University’s Center for Infection and Immunity talked about problems with antigen tests and the need for continued investment in COVID-19 testing.

A new study published in Science Advances outlines the most comprehensive data on the effects of COVID-19 vaccines on menstrual cycles to date.

On July 13, Basecare and Haier formally signed a strategic cooperation agreement in Qingdao, Shandong, China.

Two SARS-CoV-2 antigen tests from Watmind USA and Genabio Diagnostics have received Emergency Use Authorization from the US Food and Drug Administration for at-home use without a prescription.

Quest Diagnostics said Wednesday that it has internally developed a test for monkeypox and launched it, while it also plans to begin offering the US Centers for Disease Control and Prevention's monkeypox test next month.

In 2021, the total number of visits to medical and health institutions in nationwide was 8.47 billion, a year-on-year increase of 9.4%. The average citizen visits medical and health institutions 6 times a year.

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Twist Bioscience and DNAnexus said on Wednesday that they are collaborating on data analysis to help customers develop next-generation sequencing-based diagnostics.